Last update 23 Jan 2025

Gilead Sciences Ireland UC

Subsidiary Company|
Ireland

Overview

Tags

Infectious Diseases
Immune System Diseases
Digestive System Disorders
Small molecule drug
Antibody drug conjugate (ADC)
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases20
Immune System Diseases14
Nervous System Diseases3
Hemic and Lymphatic Diseases3
Neoplasms2
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug22
Antibody drug conjugate (ADC)1
Synthetic peptide1
Top 5 TargetCount
RT(Viral reverse transcriptase)5
NS5A x NS5B polymerase2
CYP3A x HIV integrase x RT2
HIV integrase x RT1
PBPs(Bacterial penicillin-binding protein)1

Related

26
Drugs associated with Gilead Sciences Ireland UC
Seladelpar
Target
PPARδ
Mechanism
PPARδ agonists
Active Org.
CymaBay Therapeutics, Inc.CymaBay Therapeutics, Inc. [+3]
Originator Org.
CymaBay Therapeutics, Inc.CymaBay Therapeutics, Inc.
Active Indication
Primary Biliary Cholangitis [+1]
Inactive Indication
Cholangitis, Sclerosing [+3]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date14 Aug 2024
Lenacapavir Sodium
Target
HIV-1 capsid
Mechanism
HIV-1 capsid inhibitors
Active Org.
Merck Sharp & Dohme LLC [+7]
Originator Org.
Gilead Sciences, Inc.Gilead Sciences, Inc.
Active Indication
HIV Infections
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date17 Aug 2022
Filgotinib Maleate
Target
JAK1
Mechanism
JAK1 inhibitors
Active Org.
Alfasigma SpAAlfasigma SpA [+5]
Originator Org.
Galapagos NVGalapagos NV
Active Indication
Colitis, Ulcerative [+7]
Inactive Indication
Arthritis, Psoriatic [+5]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date24 Sep 2020
8
Clinical Trials associated with Gilead Sciences Ireland UC
CTR20242931
/ RecruitingPhase 4
一项评估安必速在中国临床实践中的安全性和有效性的前瞻性、观察性、多中心、上市后研究
[Translation] A prospective, observational, multicenter, post-marketing study to evaluate the safety and efficacy of Anbisu in clinical practice in China
CTR20210120
/ CompletedPhase 4
一项评估必妥维治疗中国人类免疫缺陷病毒-1（HIV-1）感染患者的安全性和有效性的上市后研究
[Translation] A post-marketing study to evaluate the safety and efficacy of Bituowei in Chinese patients infected with human immunodeficiency virus-1 (HIV-1)
CTR20191588
/ CompletedPhase 3
3 期随机双盲旨在评估（B/F/TAF）与DTG+ F/TDF在治疗 HIV-1 和乙型肝炎共同感染初治成人时的安全性和有效性
[Translation] Phase 3 randomized, double-blind trial to evaluate the safety and efficacy of (B/F/TAF) versus DTG + F/TDF in treatment-naïve adults with HIV-1 and hepatitis B co-infection
100 Clinical Results associated with Gilead Sciences Ireland UC
Login to view more data
0 Patents (Medical) associated with Gilead Sciences Ireland UC
Login to view more data
1
Literatures (Medical) associated with Gilead Sciences Ireland UC
Quantification of information gained by linking claims data to an electronic health record cohort of patients with metastatic breast cancer
100 Deals associated with Gilead Sciences Ireland UC
Login to view more data
100 Translational Medicine associated with Gilead Sciences Ireland UC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
NDA/BLA
2
22
Approved
Other
2
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free